Fulgent Genetics (FLGT) Income from Continuing Operations (2016 - 2025)
Fulgent Genetics (FLGT) has disclosed Income from Continuing Operations for 11 consecutive years, with 38109000.0 as the latest value for Q4 2025.
- Quarterly Income from Continuing Operations rose 893.61% to 38109000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 158000.0 through Dec 2025, up 100.37% year-over-year, with the annual reading at 128000.0 for FY2025, 100.3% up from the prior year.
- Income from Continuing Operations hit 38109000.0 in Q4 2025 for Fulgent Genetics, up from 6809000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 200691000.0 in Q1 2021 to a low of 122884000.0 in Q4 2023.
- Historically, Income from Continuing Operations has averaged 21920100.0 across 5 years, with a median of 7949500.0 in 2024.
- Biggest five-year swings in Income from Continuing Operations: surged 11856.94% in 2021 and later plummeted 1100.74% in 2023.
- Year by year, Income from Continuing Operations stood at 103677000.0 in 2021, then plummeted by 123.22% to 24076000.0 in 2022, then crashed by 410.4% to 122884000.0 in 2023, then soared by 96.09% to 4802000.0 in 2024, then surged by 893.61% to 38109000.0 in 2025.
- Business Quant data shows Income from Continuing Operations for FLGT at 38109000.0 in Q4 2025, 6809000.0 in Q3 2025, and 19219000.0 in Q2 2025.